Effects of common genetic variants associated with colorectal cancer risk on survival outcomes after diagnosis: A large population-based cohort study.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 11 2019
Historique:
received: 03 05 2019
revised: 06 06 2019
accepted: 17 06 2019
pubmed: 5 7 2019
medline: 25 1 2020
entrez: 5 7 2019
Statut: ppublish

Résumé

Genome-wide association studies have thus far identified 130 genetic variants linked to colorectal cancer (CRC) risk (r

Identifiants

pubmed: 31271446
doi: 10.1002/ijc.32550
pmc: PMC6771941
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2427-2432

Subventions

Organisme : Cancer Research UK
ID : 12076
Pays : United Kingdom
Organisme : Medical Research Council
ID : U127527198
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0600329
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C348/A18927
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 18927
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0600237
Pays : United Kingdom
Organisme : Medical Research Council
ID : U127527202
Pays : United Kingdom
Organisme : Worldwide Cancer Research
ID : 12-1087
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00007/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_U127527198
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 22804
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U127527198
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K018647/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C31250/A22804
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M004007/1
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Références

Nature. 2019 Mar;567(7748):305-307
pubmed: 30894741
Carcinogenesis. 2012 Jul;33(7):1327-31
pubmed: 22505654
Nat Commun. 2019 May 14;10(1):2154
pubmed: 31089142
Clin Cancer Res. 2015 Aug 1;21(15):3453-61
pubmed: 25873087
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Nat Protoc. 2010 Sep;5(9):1564-73
pubmed: 21085122
Science. 1991 Mar 22;251(5000):1451-5
pubmed: 2006419
Br J Cancer. 2018 Oct;119(8):988-993
pubmed: 30135471
BMC Med. 2018 Aug 14;16(1):142
pubmed: 30103784
Cancer. 1998 Jul 15;83(2):259-66
pubmed: 9669808
Genome Res. 2012 Sep;22(9):1790-7
pubmed: 22955989
Nat Genet. 2019 Jan;51(1):76-87
pubmed: 30510241
Int J Cancer. 2017 Feb 1;140(3):581-590
pubmed: 27759937
Sci Rep. 2015 Nov 10;5:16286
pubmed: 26553438
Genet Epidemiol. 2012 Sep;36(6):538-48
pubmed: 22685040
Clin Cancer Res. 2010 Jul 15;16(14):3754-9
pubmed: 20628028
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):684-93
pubmed: 17416758
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Nat Genet. 2012 May 27;44(7):770-6
pubmed: 22634755
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):758-66
pubmed: 21357381
Nat Commun. 2016 Jan 21;7:10023
pubmed: 26831199
Carcinogenesis. 2013 Oct;34(10):2286-91
pubmed: 23712746
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Lancet Oncol. 2007 Nov;8(11):1001-6
pubmed: 17921068
Gastroenterology. 2012 Jul;143(1):51-4.e4
pubmed: 22580541
Nat Methods. 2011 Dec 04;9(2):179-81
pubmed: 22138821
Carcinogenesis. 2016 Jan;37(1):87-95
pubmed: 26586795
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590

Auteurs

Yazhou He (Y)

Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom.
Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom.
Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom.

Evropi Theodoratou (E)

Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom.
Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom.

Xue Li (X)

Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom.

Farhat V N Din (FVN)

Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom.
Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom.

Peter Vaughan-Shaw (P)

Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom.

Victoria Svinti (V)

Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom.

Susan M Farrington (SM)

Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom.
Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom.

Harry Campbell (H)

Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom.

Malcolm G Dunlop (MG)

Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom.
Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom.

Maria Timofeeva (M)

Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom.
Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH